In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including:<ul><li>The diagnosis and typical presenting symptoms of GEP-NETs</li><li>Findings from recent key phase III studies including NETTER-2 and CABINET</li><li>Recommendations for treatment sequencing</li><li>Notable clinical pearls regarding GEP-NET therapies</li><li>Current guidelines for GEP-NET care and monitoring</li></ul> Presenters:Thor R. Halfdanarson, MD Consultant, Division of Medical Oncology Professor of Oncology Associate Professor of Medicine Mayo Clinic Comprehensive Cancer Center Chair, Hepato-Pancreatico-Biliary Disease Group Rochester, MinnesotaJonathan Strosberg Professor, GI Oncology Chair, Neuroendocrine Tumor Division Moffitt Cancer Center and Research Institute Tampa, FloridaLink to full program:  <a href="https://bit.ly/3Y0JWBa" target="_blank">https://bit.ly/3Y0JWBa</a>

Clinical Care Options

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies

cco oncology podcast

CCO Oncology Podcast

Listen as Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss the diagnosis and typical presenting symptoms of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as findings from recent phase III studies including NETTER-2 and CABINET. Notable clinical pearls regarding GEP-NET therapies and current guidelines for GEP-NET care and monitoring are also highlighted.

Episode Summary

Clips